Hepatitis C
Conditions
Brief summary
The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment. A period of time without alerts will be compared to a period of time with alerts.
Detailed description
The hepatitis C virus (HCV) is one of the most common bloodborne pathogens in the United States. A large proportion of people with HCV infection progress to chronic HCV infection despite the availability of effective treatment; chronic infection can result in cirrhosis, end-stage liver disease, liver cancer, and liver-related death. HCV infection can be cured most of the time with treatment. The objective of this before and after study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of HCV treatment. A period of time without alerts will be compared to a period of time with alerts. Healthcare providers and clinic staff will not receive alerts during the before period of the study. Healthcare providers and clinic staff will receive alerts during the after period of the study.
Interventions
OTHERHepatitis C Treatment Alerts in CHORUS™
Clinical Health Outcomes Reporting & Utilization Service (CHORUS™) is a web-based healthcare analytics and reporting solution that transforms electronic health record data into meaningful information for healthcare providers. CHORUS™ generates a weekly email report that alerts clinics to patients with certain conditions who have a scheduled appointment in the coming week and may require close attention. CHORUS™ is a service provided to participating clinics and has been used by AIDS Healthcare Foundation for normal healthcare operations for quality improvement and retention in care in recent years. In the after period of this study, the alert will identify patients with active hepatitis C infection.
OTHERStandard of Care
CHORUS™ is a service provided to participating clinics and has been used by AIDS Healthcare Foundation for normal healthcare operations for quality improvement and retention in care in recent years. NO alerts identifying patients with active hepatitis C infection will be disseminated.
Sponsors
Gilead Sciences
AIDS Healthcare Foundation
Epividian
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18+ years of age * In care at an AIDS Healthcare Foundation Healthcare Center * Active, untreated HCV infection
Exclusion criteria
* \<18 years of age * Patients with active HCV infection who have a current prescription for HCV treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prescriptions for HCV treatment | End of follow-up, up to 9 months | Proportion of patients who are prescribed HCV treatment over follow-up, out of patients with a completed visit over follow-up. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| HCV RNA viral load tests | End of follow-up, up to 9 months | Frequency of HCV RNA viral load tests that occur between the first visit over follow-up and the first censoring event |
Countries
United States
Outcome results
None listed